Translational Medicine

Quick Links

* (IM Translational Medicine Faculty Profile)

John Carter

John Carter, MD

Chief, Division of Rheumatology, Internal Medicine; College of Medicine

Contact Info

Education

  • MD, Saint Louis University School of Medicine, 1996

Research Interests

  • I spend approximately 50% of my time in clinical research and have authored more than 80 peer-reviewed articles, chapters, and abstracts. My main area of research centers on Chlamydia-induced Reactive Arthritis. Other areas of research include psoriatic arthritis, ankylosing spondylitis, rheumatoid arthritis, osteoporosis, and gout.

Awards/Honors

  • Outstanding Faculty Research Award (USF Health - 2012)
  • America’s Most Compassionate Doctors Award (. - 2012)
  • Patients’ Choice Recognition Award (. - 2012)
  • Best Doctors in America (Best Doctors, Inc. - 2012)
  • America’s Top Physicians (Consumers’ Research Council of America - 2012)
  • Alpha Omega Alpha (. - 2009)

Memberships

  • Official Board Reviewer (American Board of Internal Medicine – Rheumatology, 2002 - Present)
  • National Meeting Section Co-Chair (American College of Rheumatology, 2011 - 2013)
  • NIH Reviewer (SBIR Rare Disease Grant Review: 2012/05 Council ZAR1 CNR M2, 2012 - 2012)
  • Abstract Reviewer (American College of Rheumatology National Meeting, 2010 - 2010)
  • NIH Reviewer (Innovative Therapies for Rheumatic and Skin Diseases: RFP NIH-NIAMS-BAA-07-01, 2006 - 2006)

Recent Publications

  • Carter JD, Inman RD, Whittum-Hudson J, Hudson AP. Chlamydia and chronic arthritis. Annals of medicine. 44(8) : 784-92, 2012.
  • Carter JD, Hudson AP. Recent advances and future directions in understanding and treating Chlamydia-induced reactive arthritis. Expert review of clinical immunology. 13(3) : 197-206, 2017.
  • Chen X, Eksioglu EA, Carter JD, Fortenbery N, Donatelli SS, Zhou J, Liu J, Yang L, Gilvary D, Djeu J, Wei S. Inactivation of DAP12 in PMN inhibits TREM1-mediated activation in rheumatoid arthritis. PloS one. 10(2) : e0115116, 2015.
  • Carter JD, Patelli M, Anderson SR, Prakash N, Rodriquez EJ, Bateman H, Sterrett A, Valeriano J, Ricca LR. An MRI assessment of chronic synovial-based inflammation in gout and its correlation with serum urate levels. Clinical rheumatology. 34(2) : 345-51, 2015.
  • Catherine Garcia, John D. Carter, Yih Chang L. The Potential Causality of the Microbiome and Infectious Pathogens in Primary Vasculitis Current Clinical Microbiology Reports. 1(3) : 73-80, 2014.
  • McIlwain L, Carter JD, Bin-Sagheer S, Vasey FB, Nord J. Hypersensitivity vasculitis with leukocytoclastic vasculitis secondary to infliximab. Journal of clinical gastroenterology. 36(5) : 411-3, 2003.
  • Genovese MC, Fleischmann R, Furst D, Janssen N, Carter J, Dasgupta B, Bryson J, Duncan B, Zhu W, Pitzalis C, Durez P, Kretsos K. Efficacy and safety of olokizumab in patients with rheumatoid arthritis with an inadequate response to TNF inhibitor therapy: outcomes of a randomised Phase IIb study. Annals of the rheumatic diseases. 73(9) : 1607-15, 2014.
  • Gérard HC, Carter JD, Hudson AP. Chlamydia trachomatis is present and metabolically active during the remitting phase in synovial tissues from patients with chronic Chlamydia-induced reactive arthritis. The American journal of the medical sciences. 346(1) : 22-5, 2013.
  • Terkeltaub RA, Schumacher HR, Carter JD, Baraf HS, Evans RR, Wang J, King-Davis S, Weinstein SP. Rilonacept in the treatment of acute gouty arthritis: a randomized, controlled clinical trial using indomethacin as the active comparator. Arthritis research & therapy. 15(1) : R25, 2013.
  • Carter JD, Rehman A, Guthrie JP, Gerard HC, Stanich J, Hudson AP. Attack rate of Chlamydia-induced reactive arthritis and effect of the CCR5-Delta-32 mutation: a prospective analysis. The Journal of rheumatology. 40(9) : 1578-82, 2013.
  • Gérard, Hervé C., Carter, John D., Hudson, Alan P. Chlamydia trachomatis Is Present and Metabolically Active During the Remitting Phase in Synovial Tissues From Patients With Chronic Chlamydia-induced Reactive Arthritis American Journal of the Medical Sciences. 346(1) : 22-25, 2013.
  • Carter JD, Gerard HC, Whittum-Hudson JA, Hudson AP. The molecular basis for disease phenotype in chronic Chlamydia-induced arthritis. International journal of clinical rheumatology. 7(6) : 627-640, 2012.
  • Sterrett AG, Bateman H, Guthrie J, Rehman A, Osting V, Carter JD, Ricca L, Valeriano-Marcet J. Virtual rheumatology: using simulators and a formal workshop to teach medical students, internal medicine residents, and rheumatology subspecialty residents arthrocentesis. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 17(3) : 121-3, 2011.
  • Carter JD, Gérard HC, Whittum-Hudson JA, Hudson AP. Combination antibiotics for the treatment of Chlamydia-induced reactive arthritis: is a cure in sight? International journal of clinical rheumatology. 6(3) : 333-345, 2011.
  • Carter JD, Inman RD. Chlamydia-induced reactive arthritis: hidden in plain sight? Best practice & research. Clinical rheumatology. 25(3) : 359-74, 2011.
  • Gérard HC, Whittum-Hudson JA, Carter JD, Hudson AP. The pathogenic role of Chlamydia in spondyloarthritis. Current opinion in rheumatology. 22(4) : 363-7, 2010.
  • Carter JD, Hudson AP. The evolving story of Chlamydia-induced reactive arthritis. Current opinion in rheumatology. 22(4) : 424-30, 2010.
  • Breglia MD, Carter JD. Atypical insufficiency fracture of the tibia associated with long-term bisphosphonate therapy. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 16(2) : 76-8, 2010.
  • Osting VC, Carter JD. A safety assessment of tumor necrosis factor antagonists during pregnancy. Expert opinion on drug safety. 9(3) : 421-9, 2010.
  • Gérard HC, Stanich JA, Oszust CE, Whittum-Hudson JA, Carter JD, Schumacher HR, Hudson AP. Functional CCR5 receptor protects patients with arthritis from high synovial burden of infecting Chlamydia trachomatis. The American journal of the medical sciences. 340(6) : 448-51, 2010.
  • Carter JD. Bacterial agents in spondyloarthritis: a destiny from diversity? Best practice & research. Clinical rheumatology. 24(5) : 701-14, 2010.
  • Gerard HC, Stanich JA, Whittum-Hudson JA, Schumacher HR, Carter JD, Hudson AP. Patients with Chlamydia-associated arthritis have ocular (trachoma), not genital, serovars of C. trachomatis in synovial tissue. Microbial pathogenesis. 48(2) : 62-8, 2010.
  • Carter JD, Gérard HC, Espinoza LR, Ricca LR, Valeriano J, Snelgrove J, Oszust C, Vasey FB, Hudson AP. Chlamydiae as etiologic agents in chronic undifferentiated spondylarthritis. Arthritis and rheumatism. 60(5) : 1311-6, 2009.
  • Carter JD, Hudson AP. Reactive arthritis: clinical aspects and medical management. Rheumatic diseases clinics of North America. 35(1) : 21-44, 2009.
  • Ingram, Stephanie|McKinley, Joseph M.|Vasey, Frank|Carter, John D.|Brady, Patrick G. Are inflammatory bowel disease (IBD) and pouchitis a reactive enteropathy to group D streptococci (Enterococci)? Inflammatory Bowel Diseases. 15(11) : 1609-10, 2009.
  • Carter JD, Ladhani A, Ricca LR, Valeriano J, Vasey FB. A safety assessment of tumor necrosis factor antagonists during pregnancy: a review of the Food and Drug Administration database. The Journal of rheumatology. 36(3) : 635-41, 2009.
  • Baaj AA, Vale FL, Carter JD, Rojiani AM. Granulomatosis with CNS involvement: a neuroimaging clinicopathologic correlation. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 19(2) : 194-7, 2009.
  • Carter JD, Kedar RP, Anderson SR, Osorio AH, Albritton NL, Gnanashanmugam S, Valeriano J, Vasey FB, Ricca LR. An analysis of MRI and ultrasound imaging in patients with gout who have normal plain radiographs. Rheumatology (Oxford, England). 48(11) : 1442-6, 2009.
  • Shetty A, Marcum CB, Glass LF, Carter JD. Successful treatment of pemphigus vulgaris with etanercept in four patients. Journal of drugs in dermatology : JDD. 8(10) : 940-3, 2009.
  • Gérard HC, Whittum-Hudson JA, Carter JD, Hudson AP. Molecular biology of infectious agents in chronic arthritis. Rheumatic diseases clinics of North America. 35(1) : 1-19, 2009.
  • McKinley J, Vasey F, McMillen A, Carter J, Brady P. Joint observations with lessons for rheumatologists and gastroenterologists. Inflammatory bowel diseases. 14(5) : 730-1, 2008.
  • Carter JD, Patel S, Sultan FL, Thompson ZJ, Margaux H, Sterrett A, Carney G, Murphy N, Huang Y, Valeriano J, Vasey FB. The recognition and treatment of vertebral fractures in males with chronic obstructive pulmonary disease. Respiratory medicine. 102(8) : 1165-72, 2008.
  • Brown NA, Carter JD. Urticarial vasculitis. Current rheumatology reports. 9(4) : 312-9, 2007.
  • Carter JD, Lodhi AB, Nagda SR, Ricca L, Ward C, Traina E, Thompson ZJ, Huang Y, Valeriano J, Vasey FB. Determining rheumatologists'' accuracy at assessing functional disability in rheumatoid arthritis patients using the Health Assessment Questionnaire-Disability Index. The Journal of rheumatology. 34(5) : 958-63, 2007.
  • Carter JD. Reactive arthritis: defined etiologies, emerging pathophysiology, and unresolved treatment. Infectious disease clinics of North America. 20(4) : 827-47, 2006.
  • Carter JD, Valeriano J, Vasey FB. Tumor necrosis factor-alpha inhibition and VATER association: a causal relationship. The Journal of rheumatology. 33(5) : 1014-7, 2006.
  • Cruse LM, Valeriano J, Vasey FB, Carter JD. Prevalence of evaluation and treatment of glucocorticoid-induced osteoporosis in men. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 12(5) : 221-5, 2006.
  • Vasey FB, Carter JD. Intestinal flora and psoriatic arthritis. The Journal of rheumatology. 33(10) : 2099, 2006.
  • Carter JD, Valeriano J, Vasey FB. Hydroxychloroquine as a treatment for atrophoderma of Pasini and Pierini. International journal of dermatology. 45(10) : 1255-6, 2006.
  • Carter JD. Treatment of relapsing polychondritis with a TNF antagonist. The Journal of rheumatology. 32(7) : 1413, 2005.
  • Carter JD, Valeriano J, Vasey FB, Bognar B. Refractory neurosarcoidosis: a dramatic response to infliximab. The American journal of medicine. 117(4) : 277-9, 2004.
  • Carter JD, Valeriano J, Vasey FB. Doxycycline versus doxycycline and rifampin in undifferentiated spondyloarthropathy, with special reference to chlamydia-induced arthritis. A prospective, randomized 9-month comparison. The Journal of rheumatology. 31(10) : 1973-80, 2004.
  • Lodhi AB, Carter JD, Valeriano J, Vasey FB. Can we classify psoriatic arthritis? Seminars in arthritis and rheumatism. 34(3) : 571-2, 2004.
  • Carter JD, Valeriano J, Vasey FB. Crohn disease worsened by anakinra administration. Journal of clinical rheumatology : practical reports on rheumatic & musculoskeletal diseases. 9(4) : 276-7, 2003.
  • Carter JD, Warner E. Clinical images: Tumoral calcinosis associated with sarcoidosis. Arthritis and rheumatism. 48(6) : 1770, 2003.